CWC Advisors LLC. Acquires Shares of 3,381 SPDR S&P Biotech ETF (NYSEARCA:XBI)

CWC Advisors LLC. acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 3,381 shares of the exchange traded fund’s stock, valued at approximately $334,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in SPDR S&P Biotech ETF by 30.3% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock valued at $297,575,000 after buying an additional 730,000 shares in the last quarter. Northwestern Mutual Wealth Management Co. increased its holdings in SPDR S&P Biotech ETF by 1.6% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock valued at $106,158,000 after buying an additional 18,202 shares in the last quarter. Jane Street Group LLC increased its stake in shares of SPDR S&P Biotech ETF by 68.7% during the first quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after purchasing an additional 391,333 shares in the last quarter. Bessemer Group Inc. increased its stake in shares of SPDR S&P Biotech ETF by 1.7% during the first quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock worth $87,572,000 after purchasing an additional 15,794 shares in the last quarter. Finally, Employees Retirement System of Texas increased its stake in shares of SPDR S&P Biotech ETF by 40.8% during the second quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock worth $55,984,000 after purchasing an additional 174,857 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 0.1 %

XBI stock opened at $97.15 on Friday. The stock has a market capitalization of $7.40 billion, a P/E ratio of 11.47 and a beta of 1.11. The firm has a 50-day simple moving average of $99.14 and a 200-day simple moving average of $94.60. SPDR S&P Biotech ETF has a 52 week low of $63.80 and a 52 week high of $103.52.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.